SAHIN, Meyha, Ali MERT, Ahmet Naci EMECEN, Natalija Planinc STRUNJAS, Lenka FAŠANEKOVÁ, Ayse BATIREL, Ilad Alavi DARAZAM, Shabboo ANSARI, Ghazaleh Golchoub FIROUZJAEI, Roman STEBEL, Elif Tukenmez TIGEN, Buket Erturk SENGEL, Olga DŽUPOVÁ, Maya BELITOVA, Maha ABID, Nazife Duygu DEMIRBAS, Serpil EROL, Halil KUL, Abdullah Umut PEKOK, Tuelay Uenver ULUSOY, Handan ALAY, Zahra Mohtasham AMIRI, Antonio CASCIO, Mehmet Kuersat KARADAG, Entela KOLOVANI, Nikolay MLADENOV, Ergys RAMOSACO, Oguz Resat SIPAHI, Gamze SANLIDAG, Amani EL-KHOLY, Gulay OKAY, Natalia PSHENICHNAYA, Mustafa Serhat SAHINOGLU, Sevil ALKAN, Mehmet OEZDEMIR, Bilal Ahmad RAHIMI, Gulden Eser KARLIDAG, Safak Oezer BALIN, Anna LISKOVA, Anas JOUHAR, Fahad ALMAJID, Xhumari ARTUR, Mehmet CELIK, Asfandiyar KHAN, Massimiliano LANZAFAME, Andrea MARINO, Arzu SENOL, Serkan ONCU, Mustafa UGUZ, Joanna ZAJKOWSKA and Hakan ERDEM. Profiles of primary brain abscesses and their impact on survival: An international ID-IRI study. International Journal of Infectious Diseases. London: Elsevier Ltd, 2024, vol. 147, October 2024, p. 1-8. ISSN 1201-9712. Available from: https://dx.doi.org/10.1016/j.ijid.2024.107228.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Profiles of primary brain abscesses and their impact on survival: An international ID-IRI study
Authors SAHIN, Meyha (792 Turkey), Ali MERT (792 Turkey), Ahmet Naci EMECEN (792 Turkey), Natalija Planinc STRUNJAS (705 Slovenia), Lenka FAŠANEKOVÁ (703 Slovakia, belonging to the institution), Ayse BATIREL (792 Turkey), Ilad Alavi DARAZAM (364 Islamic Republic of Iran), Shabboo ANSARI (364 Islamic Republic of Iran), Ghazaleh Golchoub FIROUZJAEI (364 Islamic Republic of Iran), Roman STEBEL (203 Czech Republic, belonging to the institution), Elif Tukenmez TIGEN (792 Turkey), Buket Erturk SENGEL (792 Turkey), Olga DŽUPOVÁ (203 Czech Republic), Maya BELITOVA (100 Bulgaria), Maha ABID (788 Tunisia), Nazife Duygu DEMIRBAS (792 Turkey), Serpil EROL (792 Turkey), Halil KUL (792 Turkey), Abdullah Umut PEKOK (792 Turkey), Tuelay Uenver ULUSOY (792 Turkey), Handan ALAY (792 Turkey), Zahra Mohtasham AMIRI (364 Islamic Republic of Iran), Antonio CASCIO (380 Italy), Mehmet Kuersat KARADAG (792 Turkey), Entela KOLOVANI (8 Albania), Nikolay MLADENOV (100 Bulgaria), Ergys RAMOSACO (8 Albania), Oguz Resat SIPAHI (792 Turkey), Gamze SANLIDAG (792 Turkey), Amani EL-KHOLY (818 Egypt), Gulay OKAY (792 Turkey), Natalia PSHENICHNAYA (643 Russian Federation), Mustafa Serhat SAHINOGLU (792 Turkey), Sevil ALKAN (792 Turkey), Mehmet OEZDEMIR (792 Turkey), Bilal Ahmad RAHIMI (4 Afghanistan), Gulden Eser KARLIDAG (792 Turkey), Safak Oezer BALIN (792 Turkey), Anna LISKOVA (703 Slovakia), Anas JOUHAR (760 Syrian Arab Republic), Fahad ALMAJID (682 Saudi Arabia), Xhumari ARTUR (8 Albania), Mehmet CELIK (792 Turkey), Asfandiyar KHAN (586 Pakistan), Massimiliano LANZAFAME (380 Italy), Andrea MARINO (380 Italy), Arzu SENOL (792 Turkey), Serkan ONCU (792 Turkey), Mustafa UGUZ (792 Turkey), Joanna ZAJKOWSKA (616 Poland) and Hakan ERDEM (792 Turkey, guarantor).
Edition International Journal of Infectious Diseases, London, Elsevier Ltd, 2024, 1201-9712.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30303 Infectious Diseases
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL URL
Impact factor Impact factor: 8.400 in 2022
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.ijid.2024.107228
UT WoS 001318567900001
Keywords in English Intravenous drug addiction; Microbiological findings; Mortality; Primary brain abscesses; Temporal lobe involvement
Tags 14110214, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 1/10/2024 10:26.
Abstract
Objectives: This study of 331 primary brain abscess (PBA) patients aimed to understand infecting agents, predisposing factors, and outcomes, with a focus on factors affecting mortality. Methods: Data were collected from 39 centers across 16 countries between January 2010 and December 2022, and clinical, radiological, and microbiological findings, along with their impact on mortality, were analyzed. Results: The patients had a mean +/- SD age of 46.8 +/- 16.3 years, with a male predominance of 71.6%. Common symptoms included headache (77.9%), fever (54.4%), and focal neurological deficits (53.5%). Gram-positive cocci were the predominant pathogens, with Viridans group streptococci identified as the most frequently isolated organisms. All patients received antimicrobial therapy and 71.6% underwent interventional therapies. The 42-day and 180-day survival rates were 91.9% and 86.1%, respectively. Significant predictors of 42-day mortality included intravenous drug addiction (HR: 6.02, 95% CI: 1.38-26.26), malignancy (HR: 3.61, 95% CI: 1.23-10.58), confusion (HR: 2.65, 95% CI: 1.19-5.88), and unidentified bacteria (HR: 4.68, 95% CI: 1.76-12.43). Significant predictors of 180-day mortality included malignancy (HR: 2.70, 95% CI: 1.07-6.81), confusion (HR: 2.14, 95% CI: 1.11-4.15), temporal lobe involvement (HR: 2.10, 95% CI: 1.08-4.08), and unidentified bacteria (HR: 3.02, 95% CI: 1.49-6.15). Conclusion: The risk of death in PBA extends beyond the infection phase, with different factors influencing the 42-day and 180-day mortality rates. Intravenous drug addiction was associated with early mortality, while temporal lobe involvement was associated with late mortality. (c) 2024 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )
PrintDisplayed: 3/10/2024 06:30